|
1
|
SV Health Investors
Boston,
Massachusetts
|
$16.5M
|
–
|
–
|
–
|
|
|
2
|
Citadel Advisors
Miami,
Florida
|
$15.6M
|
-$234K
|
-1,938
|
-1%
|
|
|
3
|
Eventide Asset Management
Boston,
Massachusetts
|
$10.9M
|
–
|
–
|
–
|
|
|
4
|
Samsara BioCapital
Palo Alto,
California
|
$10.2M
|
+$13.6M
|
+112,558
|
New
|
|
|
5
|
VV Manager
Boston,
Massachusetts
|
$8.98M
|
+$12M
|
+99,558
|
New
|
|
|
6
|
Camber Capital Management
Boston,
Massachusetts
|
$5.41M
|
–
|
–
|
–
|
|
|
7
|
|
$3.7M
|
+$843K
|
+6,981
|
+21%
|
|
|
8
|
Sphera Funds Management
Tel Aviv,
Israel
|
$3.68M
|
+$1.6M
|
+13,289
|
+48%
|
|
|
9
|
Fidelity Investments
Boston,
Massachusetts
|
$3.61M
|
+$4.22K
|
+35
|
+0.1%
|
|
|
10
|
Driehaus Capital Management
Chicago,
Illinois
|
$2.98M
|
-$339K
|
-2,807
|
-8%
|
|
|
11
|
Sio Capital Management
New York
|
$2.54M
|
+$596K
|
+4,937
|
+21%
|
|
|
12
|
Nexthera Capital
New York
|
$2.25M
|
+$216K
|
+1,789
|
+8%
|
|
|
13
|
Tekla Capital Management
Boston,
Massachusetts
|
$2.07M
|
-$243K
|
-2,010
|
-8%
|
|
|
14
|
Jennison Associates
New York
|
$1.2M
|
-$205K
|
-1,695
|
-11%
|
|
|
15
|
Vanguard Group
Malvern,
Pennsylvania
|
$1.12M
|
+$1.5M
|
+12,428
|
New
|
|
|
16
|
International Biotechnology Trust
London,
United Kingdom
|
$1.05M
|
–
|
–
|
–
|
|
|
17
|
Pentwater Capital Management
Naples,
Florida
|
$918K
|
+$384K
|
+3,181
|
+45%
|
|
|
18
|
|
$898K
|
-$7.24K
|
-60
|
-0.6%
|
|
|
19
|
Northern Trust
Chicago,
Illinois
|
$580K
|
+$776K
|
+6,432
|
New
|
|
|
20
|
Oxford Asset Management
Oxford,
United Kingdom
|
$497K
|
-$299K
|
-2,479
|
-31%
|
|
|
21
|
Geode Capital Management
Boston,
Massachusetts
|
$456K
|
+$611K
|
+5,060
|
New
|
|
|
22
|
Alyeska Investment Group
Chicago,
Illinois
|
$451K
|
-$603K
|
-5,000
|
-50%
|
|
|
23
|
Acuta Capital Partners
Redwood City,
California
|
$410K
|
+$549K
|
+4,550
|
New
|
|
|
24
|
DAFNA Capital Management
Los Angeles,
California
|
$284K
|
+$48.3K
|
+400
|
+15%
|
|
|
25
|
State Street
Boston,
Massachusetts
|
$210K
|
+$281K
|
+2,329
|
New
|
|
